Approvals for ‘Tamifly’ generics about to pour out for bioequivalence tests

Published: 2017-07-27 16:02:14

Updated: 2017-07-27 16:02:14

Approvals for generics of ‘Tamiflu,’ a influenza virus treatment whose patent is expiring on the 22^nd of August, are pouring out.

According to the Ministry of Food and Drug Safety(MFDS) on the 25^th, 15 generic drugs of ‘Tamiflu(generic name: oseltamivir phosphate)’ expiring on the 22^nd of August are getting ready for a launch after being tested for bioequivalence.

‘Tamiflu,’ a Roche’s influen...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.